These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9790114)

  • 1. Atrophic and plaquelike dermatofibrosarcoma protuberans.
    Davis DA; Sánchez RL
    Am J Dermatopathol; 1998 Oct; 20(5):498-501. PubMed ID: 9790114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrophic dermatofibrosarcoma protuberans: a case report and reappraisal of the literature.
    Sheehan DJ; Madkan V; Strickling WA; Peterson CM
    Cutis; 2004 Oct; 74(4):237-42. PubMed ID: 15551716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoid differentiation and EMA expression in fibrosarcomatous dermatofibrosarcoma protuberans.
    Arican O; Bakaris S; Bulbuloglu E; Ezberci F
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Mar; 15(1):39-44. PubMed ID: 16850098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosarcomatous dermatofibrosarcoma protuberans with giant rosettes.
    Zamecnik M
    Am J Dermatopathol; 2001 Feb; 23(1):41-5. PubMed ID: 11176051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.
    Goldblum JR
    Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.
    Díaz-Cascajo C; Weyers W; Borrego L; Iñarrea JB; Borghi S
    Am J Dermatopathol; 1997 Dec; 19(6):562-7. PubMed ID: 9415611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrophic dermatofibrosarcoma protuberans with diffuse eosinophilic infiltrate.
    Hirashima N; Misago N; Shinogi T; Inoue T; Miura Y; Narisawa Y
    J Dermatol; 2006 Jul; 33(7):486-8. PubMed ID: 16848822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatofibrosarcoma Protuberans Presenting as a Large Atrophic Plaque on the Chest.
    Saigusa R; Miyagawa T; Toyama S; Omatsu J; Miyagaki T; Masui Y; Yamada D; Sato S
    Acta Derm Venereol; 2018 Jan; 98(1):155-156. PubMed ID: 28929166
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-PDGFB rearrangement.
    Makino M; Sasaoka S; Nakanishi G; Makino E; Fujimoto W
    Diagn Pathol; 2016 Mar; 11():24. PubMed ID: 26932148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palisading and verocay body-prominent dermatofibrosarcoma protuberans: a report of three cases.
    Llatjós R; Fernández-Figueras MT; Díaz-Cascajo C; Ribera M; Ariza A
    Histopathology; 2000 Nov; 37(5):452-5. PubMed ID: 11119127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary dermatofibrosarcoma protuberans of orbit--a rare entity.
    Rahman T; Bhattacharjee K; Sarma JD; Dey D; Kuri G
    Orbit; 2013 Apr; 32(2):127-9. PubMed ID: 23448305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerosing dermatofibrosarcoma protuberans.
    Diaz-Cascajo C; Weyers W; Borghi S
    J Cutan Pathol; 1998 Sep; 25(8):440-4. PubMed ID: 9826170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
    Reimann JD; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
    Haycox CL; Odland PB; Olbricht SM; Piepkorn M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogenetic relations between giant cell fibroblastoma and dermatofibrosarcoma protuberans. CD34 staining showing the spectrum and a simulator.
    Harvell JD; Kilpatrick SE; White WL
    Am J Dermatopathol; 1998 Aug; 20(4):339-45. PubMed ID: 9700370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRAME expression in fibrosarcomatous dermatofibrosarcoma protuberans.
    Ichiki T; Ito T; Shiraishi S; Nakashima Y; Nakahara T; Oda Y
    Sci Rep; 2024 Oct; 14(1):22973. PubMed ID: 39362949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.
    Garcia C; Viehman G; Hitchcock M; Clark RE
    Dermatol Surg; 1996 Feb; 22(2):177-9. PubMed ID: 8608381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
    Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
    Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
    Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.